SGK3 and obesity disorder: Moreover, our results from Sgk3-KO mice showed protection against glucocorticoid-induced obesity while retaining sensitivity to glucocorticoids’ immune suppression effects, highlighting SGK3 as a potential therapeutic target for addressing the metabolic side effects of glucocorticoids.